Atrophic vaginitis — also called vaginal atrophy or genitourinary syndrome of menopause — is thinning, drying, and inflammation of the vaginal walls. It happens when estrogen levels drop, most often during menopause. Treatment exists and it works. The approach depends on your symptoms, your health history, and what you are comfortable with. Moisturizers, lubricants, local estrogen therapy, and newer non-hormonal options all have evidence behind them. This guide explains what each option involves, what the research actually shows, and what to expect.
What Causes Atrophic Vaginitis and Who Gets It?
Estrogen keeps vaginal tissues thick, elastic, and lubricated. When estrogen falls — during menopause, after childbirth while breastfeeding, after surgical removal of the ovaries, or during certain cancer treatments — those tissues thin and become less flexible. Blood flow decreases. The vagina produces less natural lubrication.
The North American Menopause Society reports that up to 50 percent of postmenopausal women experience symptoms of vaginal atrophy. Many do not mention it to their doctor. Some assume it is just part of aging and nothing can be done. That is not true. Treatment can restore comfort and function in most cases.
Risk factors include smoking, which lowers estrogen levels further, and having never given birth vaginally. Some women develop symptoms during breast cancer treatment because drugs like aromatase inhibitors block estrogen production. Even women who had no trouble during early menopause can develop symptoms years later as tissues continue to thin.
What Are the Symptoms of Atrophic Vaginitis?
Symptoms vary from mild to severe. The most common is vaginal dryness that does not go away with over-the-counter lubricants alone. Many women describe it as a persistent raw or scratchy feeling. Intercourse can become painful — sometimes intensely so. This pain is called dyspareunia.
Other symptoms include burning, itching, and irritation that has no clear cause like a yeast infection. Some women notice light bleeding after intercourse or a pelvic exam. Urinary symptoms are also common: feeling the need to urinate more often, urgency that feels sudden and strong, and recurrent urinary tract infections. The tissues of the urethra and bladder base also depend on estrogen, so they thin alongside the vagina.
The American College of Obstetricians and Gynecologists states that these symptoms are not dangerous on their own but they significantly affect quality of life. Sleep, sexual intimacy, exercise, and daily comfort can all be disrupted.
How To Treat Atrophic Vaginitis With Over-the-Counter Products
For mild symptoms, the first step is often a vaginal moisturizer. These are not lubricants. Moisturizers are used on a regular schedule — every two to three days — to add water to the tissues and keep them hydrated. Products like Replens have been studied and shown to improve vaginal moisture and pH over several weeks. They do not contain hormones.
Lubricants are different. They are used during sexual activity to reduce friction. Water-based, silicone-based, and oil-based options all work. Avoid products with glycerin if you are prone to yeast infections. Avoid parabens and fragrances if you have sensitive skin. The best lubricant is the one that feels comfortable and does not cause irritation.
What the research does not show: that any single brand of moisturizer or lubricant is clearly superior to others for all women. Individual response varies. Some women find silicone-based lubricants last longer. Others prefer water-based because they feel more natural. The evidence supports trying different products to find what works for you.
One non-obvious point: many women assume lubricant alone will fix their pain. For moderate to severe atrophy, lubricant helps during sex but does not treat the underlying tissue thinning. Moisturizers address the root problem more directly but still may not be enough if atrophy is advanced.
How To Treat Atrophic Vaginitis With Prescription Hormone Therapy
When over-the-counter options are not enough, local estrogen therapy is the standard medical treatment. It comes as a cream, a tablet inserted into the vagina, or a soft ring placed high in the vagina that releases estrogen slowly over three months. All three forms deliver a small dose of estrogen directly to the vaginal tissues.
Research published in the journal Menopause has found that local estrogen therapy improves vaginal moisture, elasticity, and pH within two to four weeks. Pain with intercourse decreases or resolves in most women. The dose is low enough that very little estrogen enters the bloodstream — far less than oral hormone therapy or a typical birth control pill.
The table below compares the main delivery methods:
| Method | Dosing Schedule | Typical Time to Improvement | Key Consideration |
|---|---|---|---|
| Cream | Daily for 2 weeks, then 2–3 times weekly | 2–4 weeks | Can be messy; dosing must be measured carefully |
| Vaginal tablet | Daily for 2 weeks, then twice weekly | 2–4 weeks | Discreet; no mess; applicator provided |
| Vaginal ring | Inserted every 3 months | 2–4 weeks | Requires fitting; some women find it uncomfortable |
For women who cannot use estrogen — for example, those with a history of estrogen-sensitive breast cancer — non-hormonal options exist. Ospemifene is an oral medication that acts like estrogen in vaginal tissue but not in breast tissue. The FDA has approved it for moderate to severe dyspareunia. Dehydroepiandrosterone (DHEA) vaginal inserts are another option. A 2016 study in Menopause found that DHEA improved vaginal cell health and reduced pain without raising estrogen levels in the blood.
Laser and radiofrequency devices are also being studied. Some clinics offer fractional CO2 laser treatments or radiofrequency energy to stimulate collagen production in vaginal tissue. Early studies show promise, but the evidence is not yet strong enough for major medical organizations to recommend them as first-line treatment. The American College of Obstetricians and Gynecologists has stated that more research is needed. These treatments are also not typically covered by insurance and can cost thousands of dollars.
What Are the Side Effects and Risks of Treatment?
Vaginal moisturizers and lubricants have very few side effects. Some women experience mild irritation from a specific ingredient. Switching products usually solves the problem.
Local estrogen therapy has a strong safety record. Common side effects include vaginal discharge, mild irritation at the application site, or spotting. Serious risks like blood clots or stroke are extremely rare with local estrogen because so little enters the bloodstream. The FDA requires a boxed warning on all estrogen products — including local ones — but the actual risk for local therapy is far lower than for oral estrogen. The North American Menopause Society states that local estrogen does not need a progestin to protect the uterus, which is different from oral or patch estrogen.
Ospemifene can cause hot flashes, vaginal discharge, and muscle spasms. It carries a small increased risk of blood clots similar to oral estrogen. DHEA inserts can cause vaginal discharge and, rarely, abnormal Pap smears that resolve on their own. Laser treatments can cause pain, burning, and scarring if not performed correctly. There is no long-term safety data for these devices.
- Vaginal moisturizers: Very low risk; occasional irritation from ingredients
- Local estrogen: Low risk; vaginal discharge or spotting possible; serious side effects rare
- Ospemifene: Moderate risk; hot flashes, discharge, small clot risk
- DHEA inserts: Low risk; discharge possible; limited long-term data
- Laser/radiofrequency: Uncertain risk; pain, scarring possible; no long-term safety data
Common Misconceptions About Treating Atrophic Vaginitis
A widespread myth is that vaginal atrophy is permanent and untreatable. This is false. Tissues can and do improve with treatment. Even women who have had symptoms for years see significant improvement within weeks of starting local estrogen or a consistent moisturizer routine.
Another misconception is that only women who are sexually active need treatment. Vaginal atrophy affects urination, comfort during exercise, and general daily sensation. Many women who are not sexually active still benefit from treatment because they stop having urinary tract infections or feel less irritation when walking or sitting.
Some women believe that using estrogen locally will cause weight gain, mood changes, or other systemic side effects. The evidence does not support this. A 2014 Cochrane review found that local estrogen therapy causes minimal to no change in blood estrogen levels. The effects stay mostly in the vagina.
Finally, some people think that vaginal atrophy is just dryness and can be fixed with more lubricant. As mentioned earlier, lubricant addresses friction but not tissue health. Moisturizers and prescription treatments address the underlying thinning. Using only lubricant for moderate or severe atrophy is like putting lotion on sunburned skin — it helps briefly but does not treat the damage.
What to Avoid When Treating Atrophic Vaginitis
Avoid douching. It strips the vagina of its natural protective bacteria and can worsen irritation and increase infection risk. The vagina is self-cleaning. Douching is never recommended for any reason.
Avoid scented products. Scented soaps, bubble baths, feminine sprays, and scented laundry detergents can all irritate thin vaginal tissues. Use unscented, dye-free products for washing your body and your underwear.
Avoid delaying treatment because you feel embarrassed. Vaginal atrophy is a medical condition, not a personal failing. Millions of women have it. Doctors who treat menopause see it every day. You do not need to suffer in silence.
Avoid assuming that a single treatment will work forever. Bodies change. What works at age 52 may need adjustment at age 62. Reassess your symptoms every six to twelve months with your healthcare provider. Treatment can be stepped up, stepped down, or switched as needed.
Frequently Asked Questions
How long does it take for vaginal estrogen to work?
Most women notice improvement within two to four weeks. Full benefit often takes eight to twelve weeks.
Can I use vaginal estrogen if I had breast cancer?
This depends on your cancer type and your oncologist’s advice. Some women can use it. Others choose non-hormonal options like ospemifene or DHEA.
Will treating atrophic vaginitis help with urinary symptoms?
Yes. Local estrogen therapy often reduces urinary urgency and frequency and lowers the number of urinary tract infections.
Do I need a prescription for vaginal moisturizers?
No. Vaginal moisturizers are sold over the counter. Prescription treatments are needed when moisturizers and lubricants are not enough.
